Solyco Capital

Solyco Capital is a private equity and advisory firm based in Rochester, Michigan, founded in 2017. The firm specializes in delivering capital solutions for late-stage startups and growth companies, as well as providing comprehensive financial advisory services to middle-market enterprises. In addition to capital formation and management consulting, Solyco Capital offers strategic advisory services related to real estate investments, financing, and mergers and acquisitions. With a focus on supporting the growth and development of its clients, Solyco Capital aims to facilitate successful financial transactions and enhance business operations.

John Garcia

Co-Founder and Managing Director

Sara Blackmer

Senior Partner

6 past transactions

Global Gaming League

Seed Round in 2025
Global Gaming League is a professional gaming entertainment organization that operates an online platform offering video game tournaments and events for a global audience of all ages. It aims to provide an unrivaled entertainment experience, modeled after the structure, professionalism, and competitiveness of the NFL.

SkyMirr

Series A in 2025
SkyMirr, founded in 2021 and based in Satellite Beach, Florida, specializes in innovative radio frequency (RF) technology for various applications, including broadband wireless communication and medical equipment. The company develops advanced RF technology products aimed at enhancing human life by improving the effectiveness of medical treatments for serious diseases. Additionally, SkyMirr's telecommunications solutions enable clients to deliver cost-effective and high-performance broadband wireless services to consumers. Through its commitment to advancing RF technology, SkyMirr seeks to make significant contributions to both healthcare and communication sectors.

FluidLogic

Series A in 2024
FluidLogic is a company focused on developing high-performance active hydration systems tailored for individuals in demanding environments, such as motorsports. Its product lineup includes advanced hydration solutions like the FluidLogic Flush 360 Assembly and the FluidLogic WAVE, which are designed to be mounted in vehicles for easy access. These systems ensure that users receive hydration at optimal times through a programmable application, enhancing both cognitive and physical performance. FluidLogic also offers various accessories, including the Coaxial Helmet Side Kit and the Flush 360 Helmet Side Kit, to complement its hydration systems. Committed to innovation in hydration technology, FluidLogic aims to empower individuals to maintain optimal hydration levels and improve their overall well-being.

OSDB

Seed Round in 2023
OSDB operates a digital sports media platform that connects businesses with professional athletes and teams for endorsement deals. The platform aggregates and verifies extensive information about athletes, including details on their agents, contracts, business ventures, endorsements, and philanthropic efforts. Additionally, it provides front office information and relevant contacts for each team, facilitating the establishment of partnerships. By celebrating athletes and sharing their stories, OSDB enhances fans' understanding of these sports figures while enabling businesses to forge strategic partnerships and increase engagement within the industry.

Toralgen

Seed Round in 2020
Toralgen, Inc. is a preclinical stage biopharmaceutical company based in Indianapolis, Indiana, focused on the development and commercialization of innovative human therapeutics. Established in 2017, the company specializes in a unique drug delivery technology platform that utilizes polybile nanopill delivery systems. This technology is designed to enhance the oral administration of active drug compounds, ensuring targeted delivery to specific sites within the body. By addressing the challenges associated with oral drug delivery, Toralgen's nanopills aim to improve the efficacy and safety of therapeutic agents, ultimately enhancing patient outcomes in healthcare.

Toralgen

Seed Round in 2019
Toralgen, Inc. is a preclinical stage biopharmaceutical company based in Indianapolis, Indiana, focused on the development and commercialization of innovative human therapeutics. Established in 2017, the company specializes in a unique drug delivery technology platform that utilizes polybile nanopill delivery systems. This technology is designed to enhance the oral administration of active drug compounds, ensuring targeted delivery to specific sites within the body. By addressing the challenges associated with oral drug delivery, Toralgen's nanopills aim to improve the efficacy and safety of therapeutic agents, ultimately enhancing patient outcomes in healthcare.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.